Work

Review on Regulatory Aspects of Drug Delivery Systems in Emerging Markets

Year: 2026

Type: article

Abstract: This review explores the regulatory challenges and opportunities for the development of drug delivery systems (DDS) in emerging markets such as India, China, and Brazil. It highlights the evolving regulatory frameworks, the harmonisation of national standards with international guidelines, and the rapid growth of healthcare infrastructure in these regions. Despite challenges like resource constraints, the lack of specialised regulations for novel DDS technologies, and the prevalence of counterfeit drugs, the increasing demand for advanced therapies presents significant opportunities for pharmaceutical companies. Regulatory reforms, including fast-track approval processes and investment in healthcare, create a conducive environment for the growth of DDS, especially in chronic disease management, targeted drug delivery, and biologics.

Source: Zenodo (CERN European Organization for Nuclear Research)

DOI: 10.5281/zenodo.18753958

Author: Sachin Sharma

Language: English

Topic: Pharmaceutical Economics and Policy

Subfield: Economics and Econometrics

Field: Economics, Econometrics and Finance

Domain: Social Sciences

SDGs: Good health and well-being, Industry, innovation and infrastructure

Open Access status: green

OpenAlex ID: W7131293486

FWCI:

Cites:

Cited by:

Related to: